Mode
Text Size
Log in / Sign up

Clinical Trial Search

Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.

Phase
Intervention
Population
Results posted

30 closest matches · ranked by relevance

Phase 1 N=32 A Dose-escalating Clinical Trial With KH176

MELAS · LHON · Leigh Syndrome
Primary: SAD: Change From Baseline in ECG Results by Timepoint: Corrected QT Interval According to Fridericia's Formula (QTcF) — 386.2; 395.0; 385.8; 399.3 msec
Khondrion BV Results Nov 2020 0.0% serious AE View details

Phase 2 N=23 Gene Therapy for Achromatopsia (CNGB3)

Achromatopsia
Primary: Number of Participants Meeting the Primary Outcome Defined as Any of the Below Events Occurring During the 6 Weeks Following Administration, at Least Possibly Related to…
MeiraGTx UK II Ltd Results Mar 2023 8.7% serious AE View details

Phase 2 N=11 Gene Therapy for Achromatopsia (CNGA3)

Achromatopsia
Primary: Number of Participants Meeting the Primary Outcome Defined as Any of the Below Events Occurring During the 6 Weeks Following Administration, at Least Possibly Related to…
MeiraGTx UK II Ltd Results Feb 2022 0.0% serious AE View details

Phase 2 N=78 DHA and X-Linked Retinitis Pigmentosa

Retinitis Pigmentosa · X-linked Genetic Diseases
Primary: Rate of LOSS of 31 Hertz Cone Electroretinographic Function — 0.028; 0.022 log microvolts/year — p=0.30
Retina Foundation of the Southwest Results Mar 2015 0.0% serious AE View details

Phase 2 N=35 Dose Ranging Study of Carbidopa-levodopa

Age-related Macular Degeneration
Primary: Change in Best Corrected Visual Acuity by Early Treatment Diabetic Retinopathy Study Chart Visual Scale Testing — 4.5 Change in letters (BCVA)
Snyder, Robert W., M.D., Ph.D., P.C. Results Sep 2025 0.0% serious AE View details